p44/42 (MAPK) (Erk1/2) antibody
| Antigen | p44/42 (MAPK) (Erk1/2) |
| Clonality | Monoclonal |
| Host |
Mouse |
| Reactivity |
Human |
| Application |
Western Blotting (WB), Flow Cytometry (FACS), ELISA
|
![]() |
4 references available |
| Certificates | ISO 9001:2008 |
| Catalog no. | ABIN659568 |
| Quantity | 0.1ml |
| Price | 357.50 $ Plus shipping costs $45.00 |
| Shipping to |
|
| Availability | Will be delivered in 2 to 3 Business Days |
Additional Information
| Gene ID | 5594 |
| UniProt | P28482, NP_620407.1 |
| Immunogen | Purified recombinant fragment of human MAPK1 expressed in E. Coli. |
| Isotype | IgG2b |
| Description | Other names: ERK, p38, p40, p41, ERK2, ERT1, MAPK2, PRKM1, PRKM2, P42MAPK, p41mapk, MAPK1 |
| Characteristics | Mouse Monoclonal Antibody to p44/42 MAPK (Erk1/2) |
| Specificity | Purified recombinant fragment of human MAPK1 expressed in E. Coli. |
| Molecular Weight | 41390 DA |
| Comments |
Background: Mitogen-activated protein kinases (MAPKs) are a widely conserved family of serine/threonine protein kinases involved in many cellular programs such as cell proliferation, differentiation, motility, and death. The p44/42 MAPK (Erk1/2) signaling pathway can be activated in response to a diverse range of extracellular stimuli including mitogens, growth factors, and cytokines and is an important target in the diagnosis and treatment of cancer. Upon stimulation, a sequential three-part protein kinase cascade is initiated, consisting of a MAP kinase kinase kinase (MAPKKK or MAP3K), a MAP kinase kinase (MAPKK or MAP2K), and a MAP kinase (MAPK). Multiple p44/42 MAP3Ks have been identified, including members of the Raf family as well as Mos and Tpl2/Cot. MEK1 and MEK2 are the primary MAPKKs in this pathway. MEK1 and MEK2 activate p44 and p42 through phosphorylation of activation loop residues Thr202/Tyr204 and Thr185/Tyr187, respectively. Several downstream targets of p44/42 have been identified, including p90RSK and the transcription factor Elk-1. p44/42 are negatively regulated by a family of dual-specificity (Thr/Tyr) MAPK phosphatases, known as DUSPs or MKPs, along with MEK inhibitors such as U0126 and PD98059. |
Application Details
| Application Notes | The suggested dilution is: ELISA: ~~ 1:10000. Western Bloting: ~~ 1:500 - 2000. Flow cytometry: ~~ 1:200 - 400. |
| Buffer | Purified recombinant fragment of human MAPK1 expressed in E. Coli. |
| Storage | p44/42 (MAPK) (Erk1/2) Antibody can be stored at 4?, for long term storage, store at -20?. |
| Research Area | Translation Factors, Phospho-specific antibodies, Cell Signaling, Transcription Factors, Signaling, Chromatin, Cell Structure |
| Restrictions | For Research Use only |
Publications
| Product |
Gonzalez, Raden, Rigby et al.: "Heterogeneous expression of four MAP kinase isoforms in human tissues." in: FEBS letters, Vol. 304, Issue 2-3, pp. 170-8, 1992 (PubMed).
Schiemann, Graves, Baumann et al.: "Phosphorylation of the human leukemia inhibitory factor (LIF) receptor by mitogen-activated protein kinase and the regulation of LIF receptor function by heterologous receptor activation." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 92, Issue 12, pp. 5361-5, 1995 (PubMed). Lønne, Masoumi, Lennartsson et al.: "Protein kinase Cdelta supports survival of MDA-MB-231 breast cancer cells by suppressing the ERK1/2 pathway." in: The Journal of biological chemistry, Vol. 284, Issue 48, pp. 33456-65, 2009 (PubMed). Tabakoff, Saba, Printz et al.: "Genetical genomic determinants of alcohol consumption in rats and humans." in: BMC biology, Vol. 7, pp. 70, 2009 (PubMed). |




